Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial-Reference-Cited by-同舟云学术

Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial

Published:2020-05 Issue:5 Volume:77 Page:576-580
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Briganti Alberto,Gandaglia Giorgio,Scuderi Simone,Gallina Andrea,Colombo Renzo,Fossati Nicola,Barletta Francesco,Pellegrino Antony^ORCID,Nocera Luigi^ORCID,Montorsi Francesco,Necchi Andrea^ORCID

Publisher

Elsevier BV

Subject

Urology

Reference21 articles.

1. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer;Alfred Witjes;Eur Urol,2017

2. The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study;Gandaglia;Eur Urol,2014

3. Discerning patterns and quality of neoadjuvant chemotherapy use among patients with muscle-invasive bladder cancer;Huo;Eur Urol Oncol,2019

4. European Association of Urology. https://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic.

5. From clinical trials to real-life clinical practice: the role of immunotherapy with PD-1/PD-L1 inhibitors in advanced urothelial carcinoma;Hussain;Eur Urol Oncol,2018

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer;Journal of Clinical Oncology;2024-09-06

2. Perioperative chemotherapy and immunotherapy to optimize cystectomy outcomes in the curative intent of non-metastatic muscle-invasive bladder cancer: A systematic review and meta-analysis;The French Journal of Urology;2024-09

3. Relationship of mTORC1 and ferroptosis in tumors;Discover Oncology;2024-04-07

4. Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine;BJU International;2024-03-08

5. Comprehensive Evaluation of the Ability of Comorbidity and Health Status Indices to Improve the Prediction of Perioperative Morbidity and Long-Term Survival Outcomes After Radical Cystectomy;Clinical Genitourinary Cancer;2023-12